EMEA-000406-PIP01-08-M04
Key facts
| Invented name |
Ivemend
|
| Active substance |
fosaprepitant
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0010/2014
|
| PIP number |
EMEA-000406-PIP01-08-M04
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Prevention of nausea and vomiting
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Merck Sharp & Dohme Ltd
United Kingdom
Tel. +33 180464738 Email: pip.information@merck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000406-PIP01-08-M04
|
| Compliance opinion date |
10/10/2014
|
| Compliance outcome |
positive
|